MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 461190 | Name: Re 80

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Re 80 is a retinoic acid receptor (RAR) agonist.

Chemical Structure

Re 80
Re 80
CAS#116193-60-3

Theoretical Analysis

MedKoo Cat#: 461190

Name: Re 80

CAS#: 116193-60-3

Chemical Formula: C24H26O5

Exact Mass: 394.1780

Molecular Weight: 394.46

Elemental Analysis: C, 73.08; H, 6.64; O, 20.28

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Re 80; Re-80; Re80;
IUPAC/Chemical Name
(E)-4-(1-hydroxy-3-(3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-3-oxoprop-1-en-1-yl)benzoic acid
InChi Key
PZYFNWUXYUMHGR-CPNJWEJPSA-N
InChi Code
InChI=1S/C24H26O5/c1-23(2)9-10-24(3,4)18-12-20(26)16(11-17(18)23)21(27)13-19(25)14-5-7-15(8-6-14)22(28)29/h5-8,11-13,25-26H,9-10H2,1-4H3,(H,28,29)/b19-13+
SMILES Code
Oc1c(C(/C=C(O)\c2ccc(C(O)=O)cc2)=O)cc(C(C)(C)CCC3(C)C)c3c1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 394.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Quach DT, Nguyen TT, Hiyama T. Abnormal Gastroesophageal Flap Valve Is Associated With High Gastresophageal Reflux Disease Questionnaire Score and the Severity of Gastroesophageal Reflux Disease in Vietnamese Patients With Upper Gastrointestinal Symptoms. J Neurogastroenterol Motil. 2018 Apr 30;24(2):226-232. doi: 10.5056/jnm17088. PubMed PMID: 29605978; PubMed Central PMCID: PMC5885721. 2: Meiser A, Bomberg H, Volk T, Groesdonk HV. [New technical developments for inhaled sedation]. Anaesthesist. 2017 Apr;66(4):274-282. doi: 10.1007/s00101-017-0269-5. Review. German. PubMed PMID: 28144686. 3: Reggio E, Chisari CG, Ferrigno G, Patti F, Donzuso G, Sciacca G, Avitabile T, Faro S, Zappia M. Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography. J Neurol. 2017 Mar;264(3):494-502. doi: 10.1007/s00415-016-8364-0. Epub 2016 Dec 27. PubMed PMID: 28028626. 4: Libardi CA, Catai AM, Miquelini M, Borghi-Silva A, Minatel V, Alvarez IF, Milan-Mattos JC, Roschel H, Tricoli V, Ugrinowitsch C. Hemodynamic Responses to Blood Flow Restriction and Resistance Exercise to Muscular Failure. Int J Sports Med. 2017 Feb;38(2):134-140. doi: 10.1055/s-0042-115032. Epub 2016 Dec 8. PubMed PMID: 27931053. 5: Wang TT, Dong XZ, Liu WW, Chen YH, Liu P. [In vitro studies of Raf-CREB, Akt-CREB, and CaMK II -CREB signal transduction pathway regulated by ginsenosides Rb1, Rg1 and Re]. Zhongguo Zhong Yao Za Zhi. 2014 Jun;39(11):2065-70. Chinese. PubMed PMID: 25272844. 6: Hall CL, Calt M. Computational modeling of thrombotic microparticle deposition in nonparallel flow regimes. J Biomech Eng. 2014 Nov;136(11). doi: 10.1115/1.4028134. PubMed PMID: 25085867. 7: Kievit AJ, Breugem SJ, Sierevelt IN, Heesterbeek PJ, van de Groes SA, Kremers KC, Koëter S, Haverkamp D. Dutch translation of the Kujala Anterior Knee Pain Scale and validation in patients after knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2647-53. doi: 10.1007/s00167-013-2635-4. Epub 2013 Sep 12. PubMed PMID: 24026342. 8: Keese F, Farinatti P, Pescatello L, Monteiro W. A comparison of the immediate effects of resistance, aerobic, and concurrent exercise on postexercise hypotension. J Strength Cond Res. 2011 May;25(5):1429-36. doi: 10.1519/JSC.0b013e3181d6d968. PubMed PMID: 21358433. 9: Jeon SW, Jung MK, Lee MH, Kwon JG. [Is there a relationship between leptin and the phenotype of gastroesophageal reflux disease?]. Korean J Gastroenterol. 2010 Jul;56(1):15-9. Korean. PubMed PMID: 20664313. 10: Shih FJ, Chu SH, Hsu RB, Weng HJ, Wang SS. Ethical issues of organ transplantation in Chinese community: perspectives of health professionals, legal professionals, and religious experts in Taiwan and mainland china. Transplant Proc. 2009 Jan-Feb;41(1):17-9. doi: 10.1016/j.transproceed.2008.10.048. PubMed PMID: 19249463. 11: Delmas PD, Vrijens B, Eastell R, Roux C, Pols HA, Ringe JD, Grauer A, Cahall D, Watts NB; Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators. Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab. 2007 Apr;92(4):1296-304. Epub 2007 Jan 23. Erratum in: J Clin Endocrinol Metab. 2007 Jun;92(6):2285. PubMed PMID: 17244788. 12: Orita S, Hirose M, Takahashi S, Imaida K, Ito N, Shudo K, Ohigashi H, Murakami A, Shirai T. Modifying effects of 1'-acetoxychavicol acetate (ACA) and the novel synthetic retinoids Re-80, Am-580 and Am-55P in a two-stage carcinogenesis model in female rats. Toxicol Pathol. 2004 Mar-Apr;32(2):250-7. PubMed PMID: 15200164. 13: Engedal N, Ertesvag A, Blomhoff HK. Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int Immunol. 2004 Mar;16(3):443-53. PubMed PMID: 14978018. 14: Hirasawa N, Kagechika H, Shudo K, Ohuchi K. Inhibition by retinoids of antigen-induced IL-4 production in rat mast cell line RBL-2H3. Life Sci. 2001 Feb 2;68(11):1287-94. PubMed PMID: 11233995. 15: Lee PP, Darcy KM, Shudo K, Ip MM. Interaction of retinoids with steroid and peptide hormones in modulating morphological and functional differentiation of normal rat mammary epithelial cells. Endocrinology. 1995 Apr;136(4):1718-30. PubMed PMID: 7895683. 16: Lee PP, Lee MT, Darcy KM, Shudo K, Ip MM. Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: a comparison of the retinobenzoic acid derivative RE80 with retinoic acid. Endocrinology. 1995 Apr;136(4):1707-17. PubMed PMID: 7895682. 17: Kulesz-Martin MF, Lisafeld B, Paterson J, Driscoll D, Shudo K, Roop DR, Kisiel ND. Differentiation and tumor response to retinobenzoic acid RE-80 in a malignant conversion model. Cancer Detect Prev. 1995;19(4):355-66. Erratum in: Cancer Detect Prev 1995;19(6):539. PubMed PMID: 7553678. 18: Von Schroeder HP, Hashimoto Y, Heersche JN. The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells. Teratology. 1994 Jul;50(1):54-62. PubMed PMID: 7974255. 19: Oikawa T, Okayasu I, Ashino H, Morita I, Murota S, Shudo K. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Eur J Pharmacol. 1993 Nov 2;249(1):113-6. PubMed PMID: 7506665. 20: Cárdenas A, Markovits A. Mixing and power characteristics of drag board device in shallow pool. Biotechnol Bioeng. 1987 Jul;30(1):60-5. PubMed PMID: 18576583.